Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial

• Published in: International orthopaedics Vol. 12; no. 1; p. 69
• Main Authors: Evrard, J, Doyon, F, Acar, J F, Salord, J C, Mazas, F, Flamant, R
• Format: Journal Article
• Language: English
• Published: Germany 01.04.1988
• Subjects: Aged; Cefamandole - administration & dosage; Cefamandole - pharmacology; Cefamandole - therapeutic use; Cefazolin - administration & dosage; Cefazolin - pharmacology; Cefazolin - therapeutic use; Clinical Trials as Topic; Double-Blind Method; Drainage; Drug Administration Schedule; Female; Hip Prosthesis; Humans; Male; Middle Aged; Premedication; Random Allocation; Surgical Wound Infection - prevention & control
• ISSN: 0341-2695
• DOI: 10.1007/BF00265744

The aim of this trial was to compare a 5-day course of cephazolin with a regimen of 2 days of cefamandole in 965 total hip replacements (488 in the cefamandole group and 477 in the cephazolin group). The effect of the prophylactic antibiotic on the bacterial colonization of drains (mean duration of drainage: 3.2 +/- 0.3 days) and on the susceptibility of colonizing organisms was assessed. No significant difference was observed in the percentage of infected drains between the two groups. The cefamandole group had a lower rate of Gram-negative organisms (23% versus 44%, p less than 0.01). The rate of deep infections within one year after operation was 0.7% in the cefamandole group versus 0.5% in the cephazolin group, and the difference is not significant. Cefamandole given for two days appears to be an effective prophylaxis against sepsis in total hip replacements.